Stingray Therapeutics, Inc. announced it raised $1.51 Million in an amended filing from an offering of $3 Million

May 26, 2021•over 4 years ago

Amount Raised

$1.51 Million

Round Type

seed

HoustonBiotechnology

Company Information

Company

Stingray Therapeutics, Inc.

Location

TMCX - TEXAS MEDICAL CENTER ACCELERATOR

Houston, Texas, United States

About

Stingray Therapeutics specializes in identifying targets with untapped potential to modulate the tumor microenvironment.